.

Acadia Pharmaceuticals reported $2.67M in Cost of Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 2.67M 0.28M
ALKERMES ALKS:US 58.36M 3.2M
Alnylam Pharmaceuticals ALNY:US $ 40.81M 5.18M
Biogen BIIB:US $ 484M 269.9M
Biomarin Pharmaceutical BMRN:US $ 123.13M 6.16M
Bristol Myers Squibb BMY:US $ 2677M 206M
Cara Therapeutics CARA:US 0 2.08M
Corcept Therapeutics CORT:US $ 1.32M 0.07M
Eisai 4523:JP Y 47404M 3334M
Eli Lilly And LLY:US $ 1430.5M 641.6M
Intercept Pharmaceuticals ICPT:US $ 0.31M 0.45M
Intra Cellular Therapies ITCI:US $ 4.65M 1.5M
Johnson & Johnson JNJ:US $ 7919M 321M
Moderna Inc MRNA:US 1.38B 364M
Neurocrine Biosciences NBIX:US $ 4.8M 0.2M
Pfizer PFE:US $ 8671M 1339M
Ptc Therapeutics PTCT:US $ 9.64M 0.5M
Sarepta Therapeutics SRPT:US $ 37.8M 6.35M
Seattle Genetics SGEN:US $ 106.1M 18.47M
Ultragenyx Pharmaceutical RARE:US $ 8.27M 2.17M
Vanda Pharmaceuticals VNDA:US $ 6.06M 0.39M
Vertex Pharmaceuticals VRTX:US $ 261.8M 16M
YTE INCY:US $ 45.24M 8.02M